Novartis to acquire cancer-focused MorphoSys for $2.9 billion Business Novartis to acquire cancer-focused MorphoSys for $2.9 billion Market Spectator February 6, 2024 (Reuters) -Drugmaker Novartis AG said it will acquire MorphoSys AG, a developer of cancer treatments, for 2.7... Read More Read more about Novartis to acquire cancer-focused MorphoSys for $2.9 billion
